eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
Employees - 31,
CEO - Mr. Michael Heltzen,
Sector - Healthcare,
Country - US,
Market Cap - 98.35M
Altman ZScore(max is 10): 20.15, Piotroski Score(max is 10): 1, Working Capital: $9487137, Total Assets: $13034404, Retained Earnings: $-11945958, EBIT: -7915420, Total Liabilities: $2613629, Revenue: $0
AryaFin Target Price - $1.02 - Current Price $11.75 - Analyst Target Price $-
| Ticker | EXOZ |
| Index | - |
| Curent Price | 11.75 |
| Change | -2.49% |
| Market Cap | 98.35M |
| Average Volume | 14.57K |
| Income | - |
| Sales | - |
| Book Value/Share | 1.25 |
| Cash/Share | 1.16 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 31 |
| Moving Avg 20days | 6.31% |
| Moving Avg 50days | -16.51% |
| Moving Avg 200days | -17.61% |
| Shares Outstanding | 8.37M |
| Earnings Date | Apr 02 AMC |
| Inst. Ownership | 1.17% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | - |
| Price/Book | 9.44 |
| Price/Cash | 10.12 |
| Price/FCF | - |
| Quick Ratio | 8.12 |
| Current Ratio | 8.12 |
| Debt/Equity | 0.13 |
| Return on Assets | - |
| Return on Equity | - |
| Return on Investment | - |
| Gross Margin | - |
| Ops Margin | - |
| Profit Margin | - |
| RSI | 47.84 |
| BETA(β) | - |
| From 52week Low | 38.24% |
| From 52week High | -51.02% |
| EPS | - |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | - |
| Sales past 5 Year | - |
| EPS Y/Y | - |
| Sales Y/Y | - |
| EPS Q/Q | - |
| Sales Q/Q | - |
| Sales Surprise | - |
| EPS Surprise | - |
| ATR(14) | 1.64 |
| Perf Week | 8.39% |
| Perf Month | -6.45% |
| Perf Quarter | 3.71% |
| Perf Year | - |
| Perf YTD | -28.79% |
| Target Price | - |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer